Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Hayes

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Gastro Hep Advances|August 12, 2024
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-makingHamish Innes, Philip Johnson, Scott A McDonald, et al.
BMC Endocrine Disorders|December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocolJackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Gastroenterology|June 14, 2003
Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusionPhilip N Newsome, Ingolfur Johannessen, Shelagh Boyle, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Gastroenterology|November 25, 2016
Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant RecipientMhairi C Donnelly, Stuart N Imlach, Florence Abravanel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2024
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!Jasmohan S Bajaj, Ashok Choudhury, Vinay Kumaran, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Gastro Hep Advances|August 12, 2024
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-makingHamish Innes, Philip Johnson, Scott A McDonald, et al.
BMC Endocrine Disorders|December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocolJackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Journal of Hepatology|September 9, 2014
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Scott A McDonald, Hamish A Innes, Peter C Hayes, et al.
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Gastroenterology|June 14, 2003
Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusionPhilip N Newsome, Ingolfur Johannessen, Shelagh Boyle, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Gastroenterology|November 25, 2016
Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant RecipientMhairi C Donnelly, Stuart N Imlach, Florence Abravanel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 22, 2024
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!Jasmohan S Bajaj, Ashok Choudhury, Vinay Kumaran, et al.
Pageof 17